InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Kyme Pierre. Director active across 1 company, notably Armata Pharmaceuticals, Inc.. Aggregated, 2 filings have been recorded. Activity tracked since 14 March 2025. The latest transaction was disclosed on 14 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations